review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0167-5273(02)00243-7 |
P698 | PubMed publication ID | 12163219 |
P2093 | author name string | Gerhard Schuler | |
Rainer Hambrecht | |||
Stephan Gielen | |||
Paul Christian Schulze | |||
P2860 | cites work | Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure | Q33611681 |
Catabolism in chronic heart failure | Q33896385 | ||
Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart | Q33907789 | ||
Restricted distribution of mRNA produced from a single nucleus in hybrid myotubes | Q36532250 | ||
Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. | Q40389863 | ||
Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. | Q40400999 | ||
Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure | Q40870003 | ||
Basic mechanisms in heart failure: the cytokine hypothesis | Q41188647 | ||
The "muscle hypothesis" of chronic heart failure | Q41236621 | ||
Time course of changes in markers of myogenesis in overloaded rat skeletal muscles | Q41702577 | ||
Effects of spaceflight and thyroid deficiency on hindlimb development. I. Muscle mass and IGF-I expression | Q41724144 | ||
Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity | Q45234714 | ||
Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. | Q45985895 | ||
Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation | Q47671926 | ||
Gastro-intestinal protein loss in elderly patients with cardiac cachexia. | Q51027915 | ||
Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. | Q52178500 | ||
Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure. | Q54106864 | ||
Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. | Q54112883 | ||
Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. | Q54397479 | ||
Studies on isolated human skeletal muscle fibers, including a proposed pattern of nuclear distribution and a concept of nuclear territories. | Q54402432 | ||
Prior exercise suppresses the plasma tumor necrosis factor response to bacterial lipopolysaccharide. | Q54628127 | ||
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. | Q55067141 | ||
Skeletal Muscle Function and Its Relation to Exercise Tolerance in Chronic Heart Failure | Q57422783 | ||
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD) | Q59192167 | ||
Increased expression of xanthine oxidase and insulin-like growth factor I (IGF-I) immunoreactivity in skeletal muscle after strenuous exercise in humans | Q60018830 | ||
Alterations of skeletal muscle in chronic heart failure | Q67487930 | ||
Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity | Q68004599 | ||
Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure | Q68084268 | ||
Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow | Q68448350 | ||
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure | Q68524243 | ||
Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure | Q68698026 | ||
Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure | Q69778142 | ||
Physical training improves skeletal muscle metabolism in patients with chronic heart failure | Q70625396 | ||
Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart | Q71102878 | ||
Fat malabsorption in elderly patients with cardiac cachexia | Q71160571 | ||
Circulatory status and response to cardiac rehabilitation in patients with heart failure | Q71613813 | ||
Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles | Q72168544 | ||
Increased resting metabolic rate in patients with congestive heart failure | Q72290760 | ||
Myonuclear loss in atrophied soleus muscle fibers | Q73148152 | ||
Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure | Q73270987 | ||
Elevated soluble CD14 receptors and altered cytokines in chronic heart failure | Q73370485 | ||
Increased inducible nitric oxide synthase in skeletal muscle biopsies from patients with chronic heart failure | Q73593462 | ||
Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha | Q73742574 | ||
Prognostic value of serum cytokines in patients with congestive heart failure | Q73784678 | ||
Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial | Q73920473 | ||
Endotoxaemia, production of tumour necrosis factor alpha and polymorphonuclear neutrophil activation following strenuous exercise in humans | Q74532688 | ||
Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance | Q74635681 | ||
Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production but decreased tumour necrosis factor-alpha production after a 5-km run | Q77479048 | ||
Skeletal muscle metabolism limits exercise capacity in patients with chronic heart failure | Q77500852 | ||
Apoptosis of myofibres and satellite cells: exercise-induced damage in skeletal muscle of the mouse | Q77793920 | ||
Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha | Q77905072 | ||
Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle | Q77958718 | ||
P433 | issue | 1 | |
P921 | main subject | heart failure | Q181754 |
chronic heart failure | Q11829287 | ||
P304 | page(s) | 141-149 | |
P577 | publication date | 2002-09-01 | |
P1433 | published in | International Journal of Cardiology | Q2357863 |
P1476 | title | Chronic heart failure and skeletal muscle catabolism: effects of exercise training | |
P478 | volume | 85 |
Q42745683 | A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart. |
Q36000038 | Activation of PPARδ signaling improves skeletal muscle oxidative metabolism and endurance function in an animal model of ischemic left ventricular dysfunction. |
Q37940294 | Aerobic exercise training in heart failure: impact on sympathetic hyperactivity and cardiac and skeletal muscle function. |
Q36844820 | Aldehydes and disturbance of carbohydrate metabolism: some consequences and possible approaches to its normalization |
Q34781822 | Analysis of skeletal muscle gene expression patterns and the impact of functional capacity in patients with systolic heart failure |
Q37960096 | Cachexia and sarcopenia: emerging syndromes of importance in dogs and cats |
Q36332873 | Cachexia in chronic heart failure: prognostic implications and novel therapeutic approaches |
Q24806378 | Cancer, inflammation and the AT1 and AT2 receptors |
Q46917530 | Delta-9-tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production |
Q43795163 | Effect of home-based walking on performance and quality of life in patients with heart failure. |
Q39427692 | Effects of exercise training on anabolic and catabolic markers in patients with chronic heart failure: a systematic review |
Q34205317 | Exercise training in childhood cancer survivors with subclinical cardiomyopathy who were treated with anthracyclines |
Q36339431 | Exercise training in chronic heart failure: improving skeletal muscle O2 transport and utilization |
Q33567653 | Exercise training modulates the nitric oxide synthase profile in skeletal muscle from old rats |
Q37209367 | FSTL1 as a Potential Mediator of Exercise-Induced Cardioprotection in Post-Myocardial Infarction Rats |
Q37758421 | Functional electrical stimulation of lower limbs in patients with chronic heart failure |
Q36979025 | Implications of chronic heart failure on peripheral vasculature and skeletal muscle before and after exercise training |
Q57804527 | Interleukin-1 Beta and Tumor Necrosis Factor Alpha Upregulation and Nuclear Factor Kappa B Activation in Skeletal Muscle from a Mouse Model of Chronic/Progressive Parkinson Disease |
Q42526658 | Lymphocyte antioxidant response and H2O2 production after a swimming session: gender differences. |
Q47721390 | Measuring body composition in chronic heart failure: a comparison of methods |
Q36526900 | Metabolic and immunologic derangements in cardiac cachexia: where to from here? |
Q53473229 | Modulation of Murf-1 and MAFbx expression in the myocardium by physical exercise training. |
Q35850050 | Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance |
Q60302201 | Nutritional risk index as a predictor of mortality in acutely decompensated heart failure |
Q35944971 | Physical activity and atherosclerosis: which animal model? |
Q37483737 | Reactive oxygen species: impact on skeletal muscle |
Q37994970 | Skeletal muscle abnormalities in chronic heart failure |
Q36820423 | Skeletal muscle function during exercise-fine-tuning of diverse subsystems by nitric oxide |
Q33966821 | Understanding and managing cancer cachexia |
Q90671795 | What and How Can Physical Activity Prevention Function on Parkinson's Disease? |